A roundup of the latest pharma and healthcare news from Turkey including Roche Turkey’s digital platform for HCPs and patients, big pharma’s aid to earthquake victims, the Scientific and Technological Research Council’s new manufacturing facility and IHH Healthcare’s acquisition of Kent Health Group.


Pharma 2023: Roche Turkey’s Digital Platform for HCPs and Patients (PharmExec)

Gizem Özbayraç, head of business, agility, digital, and customer excellence, Roche, presented on the topic: “Roche Turkey has developed a digital platform for patients and healthcare professionals (HCPs) to manage the chronic disease journey remotely,” at Pharma 2023. True to the topic, Özbayraç’s first detailed the challenges in Turkey that spurred the development of this platform, initially in multiple sclerosis (MS).


Sanofi, Pfizer and AbbVie join roster of pharmas marshalling relief for Turkey and Syria after deadly quake (Fierce Pharma)

As rescue efforts continue in the wake of a cataclysmic earthquake on the border of Turkey and Syria, drugmakers near and far are rushing to offer aid.

Novartis and its generics arm Sandoz are putting up USD 1 million for the cause. At present, the companies are working to identify the right partners to “make sure this support gets to those most in need,” Novartis said in a press release.


Türkiye’s research council opens pharmaceutical production facility (Daily Sabah)

The Scientific and Technological Research Council of Türkiye (TÜBITAK) and Marmara Research Center (MAM) launched the Medical Biotechnology Research Center (MEDIBIYO) on Tuesday to produce biotechnological medications and vaccines on a pilot scale, as well as drugs to combat cancer.

Situated at the TÜBITAK MAM Gebze campus in Kocaeli province adjacent to Istanbul, the MEDIBIYO facility has the capacity to produce biotechnological drugs and vaccines that comply with good manufacturing practice (GMP) standards. It supports many industrial establishments in Türkiye and is ready for operation.


After Turkey’s earthquake, a grave mental health toll looms (Reuters)

Experts fear children will be hardest hit. The United Nations International Children’s Emergency Fund (UNICEF) said many of the more than 5.4 million children who live across the quake zone were at risk of developing anxiety, depression and post-traumatic stress disorder.


Türkiye to become ‘global centre of attraction’ in healthcare, Erdogan vows (TRT World)

Türkiye’s President Recep Tayyip Erdogan has vowed to turn his country into a “global centre of attraction” in the field of healthcare.

“We are determined to make Türkiye a global centre of attraction in healthcare and not just a provider of services to its own citizens,” Erdogan said on Saturday at the opening ceremony of a city hospital in the northwestern Kocaeli province.


IHH Healthcare acquires Turkey-based Kent Health Group (The Star)

IHH Healthcare Bhd has acquired Kent Health Group, the largest private hospital operator in Izmir, Turkiye.

In a statement yesterday, IHH said its subsidiary, Acibadem Healthcare Group, had entered into definitive agreements to acquire 100% of Kent Health Group.

Founded in 2004, Kent Health Group operates the largest private hospital in Izmir, namely the 340-bed Izmir Kent Hospital with an attached cancer centre, as well as two medical centres in the city.


Türkiye’s biotech firm develops device to treat resistant hypertension (TRT World)

A Turkish medical firm has developed a device for the treatment of resistant hypertension, or high blood pressure, that does not respond well to aggressive medical treatment.

INVAMED Medical Device Technologies said they have produced the Delta Modulator RDN device for this purpose.